Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMENHCI)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
kavain; 3155-48-4; DL-KAWAIN; Neuronica; Cavain; DL-Kavain; 1635-33-2; MLS000069449; SMR000059008; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-(2-phenylethenyl)-; Gonosan; 2H-Pyran-2-one, 5,6-dihydro-4-methoxy-6-styryl-; kavaine; trans-5,6-Dihydro-4-methoxy-6-(2-phenylethenyl)-2H-pyran-2-one; C14H14O3; rac-Kavain; 2,6-Heptadienoic acid, 5-hydroxy-3-methoxy-7-phenyl-, delta-lactone; D,L-Kawin; Kawain, DL-; Kawain (+-)-form; DL-Kavain, primary pharmaceutical reference standard; kavain, (R)-(E)-isomer; EINECS 207-907-2; CCRIS 9373
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
||||||||||||||||
|
||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Colon
Colorectal adenocarcinoma
Fibroblast
Nasopharyngeal carcinoma
Hematopoietic system
Normal
Kidney
Normal (Immortalized)
Liver
Hepatoblastoma
Lung
Lung adenocarcinoma
Non-small cell lung carcinoma
Prostate
Prostate carcinoma
Skin
Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
